Jci_page_head_homepage_01 Jci_page_head_homepage_02
Elena Koustova, Yoshitatsu Sei, Linda Fossom, Mei-Ling Wei, Peter N.R. Usherwood, N. Bradley Keele, Michael A. Rogawski, Anthony S. Basile
Published in Volume 107, Issue 6
J Clin Invest. 2001; 107(6):737–744 doi:10.1172/JCI11500
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

LP-BM5 mouse brain IgG modulates [3H]AMPA binding. (a) IgG from LP-BM5 brain (protein A/G, filled squares; T-gel column, filled diamonds) or serum (protein A/G, filled circles), or control mouse brain (protein A/G, open squares), or serum (protein A/G, open circles) were added to a competition assay for [3H]AMPA. Curves represent data from a single assay performed in triplicate. (b) An IC50 volume of infected mouse brain IgG (filled squares) inhibited [3H]AMPA binding to its high-affinity site, while noncompetitively enhancing binding to its low-affinity site relative to control IgG preparations (open squares) or buffer (filled circles). Inset represents a Scatchard-Rosenthal plot of data from control and LP-BM5 IgG. B/F, bound/free.